PolyPeptide Group Future Growth

Future criteria checks 4/6

PolyPeptide Group is forecast to grow earnings and revenue by 64.2% and 13.2% per annum respectively. EPS is expected to grow by 65.2% per annum. Return on equity is forecast to be 6.1% in 3 years.

Key information

64.2%

Earnings growth rate

65.2%

EPS growth rate

Life Sciences earnings growth22.5%
Revenue growth rate13.2%
Future return on equity6.1%
Analyst coverage

Low

Last updated15 Nov 2024

Recent future growth updates

Recent updates

PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 19% Below Its Share Price

Nov 11
PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 19% Below Its Share Price

PolyPeptide Group (VTX:PPGN) Is Making Moderate Use Of Debt

Oct 21
PolyPeptide Group (VTX:PPGN) Is Making Moderate Use Of Debt

Sentiment Still Eluding PolyPeptide Group AG (VTX:PPGN)

Sep 16
Sentiment Still Eluding PolyPeptide Group AG (VTX:PPGN)

Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?

Jun 19
Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?

Further Upside For PolyPeptide Group AG (VTX:PPGN) Shares Could Introduce Price Risks After 33% Bounce

Mar 14
Further Upside For PolyPeptide Group AG (VTX:PPGN) Shares Could Introduce Price Risks After 33% Bounce

PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 99% Above Its Share Price

Mar 13
PolyPeptide Group AG's (VTX:PPGN) Intrinsic Value Is Potentially 99% Above Its Share Price

PolyPeptide Group AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 18
PolyPeptide Group AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors Shouldn't Be Too Comfortable With PolyPeptide Group's (VTX:PPGN) Robust Earnings

Mar 23
Investors Shouldn't Be Too Comfortable With PolyPeptide Group's (VTX:PPGN) Robust Earnings

Earnings and Revenue Growth Forecasts

SWX:PPGN - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202648337-14554
12/31/202541513-29324
12/31/2024348-12-51114
6/30/2024324-293085N/A
3/31/2024322-40561N/A
12/31/2023320-51-2036N/A
9/30/2023300-44-621N/A
6/30/2023279-37-104-35N/A
3/31/2023280-14-89-15N/A
12/31/20222818-735N/A
9/30/202228120-747N/A
6/30/202228133-759N/A
3/31/202228140-4833N/A
12/31/202128247-2057N/A
9/30/202127748-467N/A
6/30/2021271481377N/A
3/31/2021248401063N/A
12/31/202022431649N/A
12/31/2019203263656N/A
12/31/201818124523N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PPGN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.3%).

Earnings vs Market: PPGN is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: PPGN is expected to become profitable in the next 3 years.

Revenue vs Market: PPGN's revenue (13.2% per year) is forecast to grow faster than the Swiss market (4.2% per year).

High Growth Revenue: PPGN's revenue (13.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: PPGN's Return on Equity is forecast to be low in 3 years time (6.1%).


Discover growth companies